Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
A new evidence-based framework is helping clinicians better manage breast cancer-related lymphedema. Researchers synthesized 31 evidence sources into 37 best-practice items organized across 3 core domains — covering implementation principles, intensive treatment, and long-term maintenance. The framework centers on complete decongestive therapy (CDT) and aims to close the gap between expert guidance and real-world care.
Breast cancer-related lymphedema (BCRL) is a common and often undertreated complication — but a new evidence-based framework could change that. Researchers reviewed 558 records and distilled 31 high-quality sources into a structured guide for delivering complete decongestive therapy (CDT), published in the Asia-Pacific Journal of Oncology Nursing. The result: 37 best-evidence items organized across 3 core domains to standardize care from diagnosis through long-term self-management.
The framework walks clinicians through the full care continuum — from identifying the right patients and assessing risk, to executing the intensive treatment phase (manual lymphatic drainage, compression therapy, skin care, and therapeutic exercise), to navigating the often-tricky transition into patient-led maintenance care.
Key Takeaways:
Why it matters: BCRL affects a significant portion of breast cancer survivors, yet care delivery remains inconsistent. This framework gives clinicians a practical, phased roadmap — and highlights where telehealth and specialist nurses can help bridge the gap between evidence and everyday practice.
